AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9431344 — intervention group
Group type: COMPARATOR
Intervention: Interval appendectomy
Number of subjects: 0
Study 9431344 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in treatment
Number of subjects: 0
Study 8172795 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (timing of quality of life assessment)
Number of subjects: 1389
Study 8172795 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 1389
Study 2597938 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery instructions
Number of subjects: 0
Study 2597938 — intervention group
Group type: COMPARATOR
Intervention: Muscular activity (pressure applied)
Number of subjects: 0
Study 189326 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH/MSH 4‐10
Number of subjects: 20
Study 189326 — intervention group
Group type: COMPARATOR
Intervention: Diluent
Number of subjects: 20
Study 31691599 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive joint position-matching task with the dominant leg
Number of subjects: 24
Study 31691599 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive joint position-matching task with the non-dominant leg
Number of subjects: 24
Study 31691599 — intervention group
Group type: COMPARATOR
Intervention: Passive joint position-matching task
Number of subjects: 24
Study 28183449 — intervention group
Group type: EXPERIMENTAL
Intervention: High meat diet (HMD)
Number of subjects: 49
Study 25596659 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy (two cycles of cisplatin 100 mg/m(2) during radiotherapy)
Number of subjects: 151
Study 25596659 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus panitumumab (three cycles of panitumumab 9 mg/kg every 3 weeks administered with radiotherapy)
Number of subjects: 151
Study 25596659 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy
Number of subjects: 151
Study 25596659 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus panitumumab
Number of subjects: 151
Study 23400966 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision (MC)
Number of subjects: 675
Study 23400966 — intervention group
Group type: COMPARATOR
Intervention: Control (uncircumcised men)
Number of subjects: 675
Study 21546926 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dissonance intervention (N = 21)
Number of subjects: 64
Study 21546926 — intervention group
Group type: EXPERIMENTAL
Intervention: Social consensus intervention (N = 22)
Number of subjects: 64
Study 21546926 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (N = 21)
Number of subjects: 64
Study 19752406 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational letter indicating stroke symptoms, bookmark, and sticker with emergency medical services' telephone number
Number of subjects: 741
Study 19752406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 741
Study 17608028 — intervention group
Group type: EXPERIMENTAL
Intervention: FavId, a patient-specific idiotypic vaccine
Number of subjects: 0
Study 15150204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 119
Study 15150204 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride
Number of subjects: 119
Study 11252687 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (Vioxx) 12.5 mg qd
Number of subjects: 483
Study 11252687 — intervention group
Group type: COMPARATOR
Intervention: Arthrotec (diclofenac 50 mg/misoprostol 200 mcg bid)
Number of subjects: 483
Study 9891257 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhode Island Stress and Coping Inventory (RISCI)
Number of subjects: 466
Study 7997000 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% malathion lotion
Number of subjects: 193
Study 7997000 — intervention group
Group type: COMPARATOR
Intervention: 0.3% d-phenothrin lotion
Number of subjects: 193
Study 3338252 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar carbon monoxide measurement after smoking a cigarette
Number of subjects: 101
Study 3338252 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxyhaemoglobin measurement after smoking a cigarette
Number of subjects: 101
Study 3338252 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar CO measurement taken 5 min after smoking
Number of subjects: 101
Study 3338252 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar CO and carboxyhaemoglobin boosts after breathing a 2% CO gas mixture
Number of subjects: 101
Study 3338252 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar CO boost measurement after smoking
Number of subjects: 101
Study 31496353 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathy voice quality in tone identification tests
Number of subjects: 0
Study 31496353 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized syllables with breathy voice
Number of subjects: 0
Study 31496353 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural stimuli with breathy voice
Number of subjects: 0
Study 31496353 — intervention group
Group type: COMPARATOR
Intervention: Modal voice quality in tone identification tests
Number of subjects: 0
Study 29537618 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor exercise park for older people
Number of subjects: 0
Study 28314552 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 57
Study 28314552 — intervention group
Group type: COMPARATOR
Intervention: Attention control class
Number of subjects: 57
Study 25549314 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 13
Study 25549314 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 13
Study 23034558 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Visiting Nurse (HVN) intervention
Number of subjects: 499
Study 23034558 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 499
Study 20215042 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity in individuals with active epilepsy
Number of subjects: 125
Study 20215042 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical comorbidity in individuals with inactive epilepsy
Number of subjects: 125
Study 18310736 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief relaxation method (BR)
Number of subjects: 90
Study 18310736 — intervention group
Group type: EXPERIMENTAL
Intervention: Music distraction (MD)
Number of subjects: 90
Study 18310736 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 90
Study 16562684 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 30 microg/kg
Number of subjects: 30
Study 16562684 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 60 microg/kg
Number of subjects: 30
Study 16562684 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 100 microg/kg
Number of subjects: 30
Study 16562684 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 12950572 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional root-canal hand instrumentation
Number of subjects: 40
Study 12950572 — intervention group
Group type: COMPARATOR
Intervention: Noninstrumentation technique (NIT)
Number of subjects: 40
Study 11027424 — intervention group
Group type: EXPERIMENTAL
Intervention: CarboMIP regimen (cisplatin 60 mg m(‐2) and carboplatin 200 mg m(‐2) with mitomycin 6 mg m(‐2) and ifosfamide 3 g m(‐2))
Number of subjects: 305
Study 11027424 — intervention group
Group type: COMPARATOR
Intervention: MIP regimen (cisplatin 50 mg m(‐2) with mitomycin 6 mg m(‐2) and ifosfamide 3 g m(‐2))
Number of subjects: 305
Study 9099320 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 82
Study 9099320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 8017600 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous regional analgesia (interpleural and epidural infusions)
Number of subjects: 2630
Study 8017600 — intervention group
Group type: COMPARATOR
Intervention: Intravenous opioid administration
Number of subjects: 2630
Study 3065741 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP regimen
Number of subjects: 973
Study 3065741 — intervention group
Group type: COMPARATOR
Intervention: COP regimen
Number of subjects: 973
Study 3065741 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil (daily indefinite course)
Number of subjects: 973
Study 3065741 — intervention group
Group type: COMPARATOR
Intervention: Intermittent chlorambucil-prednisone
Number of subjects: 973
Study 29582088 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOICE intervention (n=150)
Number of subjects: 304
Study 29582088 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=154)
Number of subjects: 304
Study 26198928 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin D3 every five days for 12 weeks
Number of subjects: 94
Study 26198928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 23289373 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed message with additive counterfactual thinking
Number of subjects: 0
Study 23289373 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed message with subtractive counterfactual thinking
Number of subjects: 0
Study 21251831 — intervention group
Group type: COMPARATOR
Intervention: No additional load
Number of subjects: 13
Study 21251831 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 kg load suspended from the waist
Number of subjects: 13
Study 21251831 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 kg load suspended from the waist
Number of subjects: 13
Study 21251831 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 kg load across the rear of the shoulders
Number of subjects: 13
Study 21251831 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 kg load across the rear of the shoulders
Number of subjects: 13
Study 18812129 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy combined with cataract surgery
Number of subjects: 80
Study 18812129 — intervention group
Group type: COMPARATOR
Intervention: Significant cataract only (control group)
Number of subjects: 80
Study 16131531 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (100 microg/kg + 10 microg/kg/h)
Number of subjects: 144
Study 16131531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 16131531 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 144
Study 16131531 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional morphine
Number of subjects: 144
Study 14571607 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (250 micrograms/h for 72 hours) combined with TCM-WM
Number of subjects: 60
Study 14571607 — intervention group
Group type: COMPARATOR
Intervention: Baseline treated group (TCM-WM only)
Number of subjects: 60
Study 11084248 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflurax (pectin-based anti-reflux formulation)
Number of subjects: 2
Study 11084248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 9184259 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple trapezectomy without interposition material
Number of subjects: 20
Study 1583939 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard gamble utility
Number of subjects: 73
Study 1583939 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorical rating utility
Number of subjects: 73
Study 1583939 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard gamble utilities
Number of subjects: 73
Study 3792351 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 17
Study 3792351 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil
Number of subjects: 17
Study 29861254 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrapatellar bandage
Number of subjects: 40
Study 27465906 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated formulation
Number of subjects: 0
Study 27465906 — intervention group
Group type: EXPERIMENTAL
Intervention: Second formulation prototype (single-unit core and enteric-coating film)
Number of subjects: 0
Study 27465906 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release formulation
Number of subjects: 0
Study 23740231 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (NPX) 1000 mg/d
Number of subjects: 80
Study 23740231 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 80
Study 23039926 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-tiered oral health education programme
Number of subjects: 154
Study 23039926 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 154
Study 19855293 — intervention group
Group type: EXPERIMENTAL
Intervention: SITA SWAP tests
Number of subjects: 27
Study 18502251 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) microskills
Number of subjects: 67
Study 15835284 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (m-CIMT)
Number of subjects: 30
Study 15835284 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 12781934 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication self-management program
Number of subjects: 43
Study 12781934 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 43
Study 10475621 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy and bone marrow transplant with HLA-identical sibling donor
Number of subjects: 9
Study 10475621 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy and bone marrow transplant with alternative donor (non-HLA-identical sibling)
Number of subjects: 9
Study 10475621 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy and bone marrow transplant with autotransplant
Number of subjects: 9
Study 10475621 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (interferon and/or chemotherapy)
Number of subjects: 9
Study 10475621 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference between donor types
Number of subjects: 9
Study 10475621 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative donor versus autotransplant
Number of subjects: 9
Study 8623168 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine emulsion
Number of subjects: 101
Study 8623168 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 101
Study 1911473 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 2000
Study 6126894 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 12
Study 6126894 — intervention group
Group type: EXPERIMENTAL
Intervention: Metipranolol (5 mg)
Number of subjects: 12
Study 6126894 — intervention group
Group type: EXPERIMENTAL
Intervention: Metipranolol (20 mg)
Number of subjects: 12
Study 6126894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31013204 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 22
Study 31013204 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 mg/kg Dextrose)
Number of subjects: 22
Study 29244251 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (folic acid 2.5 mg/day, vitamin B6 50 mg/day, vitamin B12 1 mg/day)
Number of subjects: 4810
Study 29244251 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin supplementation
Number of subjects: 4810
Study 29244251 — intervention group
Group type: COMPARATOR
Intervention: Control group (no B vitamin supplementation)
Number of subjects: 4810
Study 25833778 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg of anthocyanins twice daily
Number of subjects: 58
Study 25029830 — intervention group
Group type: EXPERIMENTAL
Intervention: Periosteal dissector
Number of subjects: 220
Study 25029830 — intervention group
Group type: COMPARATOR
Intervention: Electric scalpel
Number of subjects: 220
Study 22956832 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-band activity (60-80 Hz) in left Brodmann area 9 (BA9)
Number of subjects: 25
Study 22956832 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha frequencies (10-14 Hz) in Brodmann area 6
Number of subjects: 25
Study 19513797 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable silicone gastric banding (LASGB)
Number of subjects: 100
Study 19513797 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic vertical banded gastroplasty (LVBG)
Number of subjects: 100
Study 17220905 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine (Flu) 40 mg/m(2)/day x 5 days
Number of subjects: 32
Study 17220905 — intervention group
Group type: COMPARATOR
Intervention: Cladribine (Clad) 10 mg/m(2)/day x 5 days plus oral busulfan (1 mg/kg q6 h x 2 days) and total body irradiation 200 cGy
Number of subjects: 32
Study 15079003 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT) with agalsidase beta
Number of subjects: 22
Study 15079003 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 22
Study 12172831 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 month combined dietary-behavioural-exercise intervention
Number of subjects: 177
Study 12172831 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 month continued intervention
Number of subjects: 177
Study 12172831 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 177
Study 9522145 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 1044
Study 9522145 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 10 mg
Number of subjects: 1044
Study 9522145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1044
Study 8611993 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar scissors (Evershears, Everest Medical)
Number of subjects: 80
Study 8611993 — intervention group
Group type: COMPARATOR
Intervention: Monopolar scissors (Endoshears, United States Surgical Corporation)
Number of subjects: 80
Study 2751738 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate sustained-release capsules (Olicard 40 retard)
Number of subjects: 12
Study 2751738 — intervention group
Group type: COMPARATOR
Intervention: Standard‐release formulation of isosorbide‐5‐mononitrate
Number of subjects: 12
Study 155098 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol, administered twice a day
Number of subjects: 110
Study 155098 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine, administered four times a day
Number of subjects: 110
Study 31270082 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) treatment
Number of subjects: 180
Study 31270082 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 180
Study 28130888 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm lidocaine and tetracaine patch
Number of subjects: 339
Study 28130888 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 339
Study 26089305 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 946
Study 26089305 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural therapy (ICBT)
Number of subjects: 946
Study 26089305 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 946
Study 26089305 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (exercise, ICBT, TAU)
Number of subjects: 946
Study 23157172 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-salt treatment 6.6 mg/m(3)
Number of subjects: 39
Study 23157172 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt treatment 10.8 mg/m(3)
Number of subjects: 39
Study 23157172 — intervention group
Group type: COMPARATOR
Intervention: Placebo 0.3 mg/m(3)
Number of subjects: 39
Study 21793716 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 27
Study 21793716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 18615480 — intervention group
Group type: EXPERIMENTAL
Intervention: ERCC1 8092 C > A allele
Number of subjects: 267
Study 18615480 — intervention group
Group type: EXPERIMENTAL
Intervention: CC haplotype of ERCC1
Number of subjects: 267
Study 16707635 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-octylcyanoacrylate
Number of subjects: 51
Study 16707635 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 51
Study 15112094 — intervention group
Group type: EXPERIMENTAL
Intervention: Imageless computer-assisted implantation technique
Number of subjects: 80
Study 15112094 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 80
Study 11273941 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketorolac (Group K)
Number of subjects: 50
Study 11273941 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group C)
Number of subjects: 50
Study 10423632 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 microg PGE (1) administered intravenously (i.v.) in 100 mL saline solution over 2 hours each day for 14 days.
Number of subjects: 50
Study 10423632 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously (i.v.) in 100 mL saline solution over 2 hours each day for 14 days.
Number of subjects: 50
Study 8287162 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide levels after ingestion of Sustacal
Number of subjects: 3711
Study 8287162 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical definitions for type of diabetes
Number of subjects: 3711
Study 8287162 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant analysis
Number of subjects: 3711
Study 8287162 — intervention group
Group type: COMPARATOR
Intervention: Clinically derived definitions
Number of subjects: 3711
Study 3549323 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg given orally at bedtime for 7 consecutive days
Number of subjects: 0
Study 3549323 — intervention group
Group type: COMPARATOR
Intervention: Triazolam 0.5 mg given orally at bedtime for 7 consecutive days
Number of subjects: 0
Study 30043714 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin plus 10 mg tadalafil daily for 7 days
Number of subjects: 80
Study 30043714 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg tamsulosin plus placebo
Number of subjects: 80